The CME/CE program will provide a comprehensive update on psoriatic arthritis (PsA), focusing on the latest insights into immunopathology, therapeutic targets, and specific oral therapies, including TYK2 inhibitors. The expert faculty, Rebecca Haberman, MD, will analyze the efficacy and safety of current and emerging therapies, including the role of these newer treatments in personalizing patient care, improving adherence, and ultimately enhancing quality of life in patients with psoriatic arthritis. Margaret A. Coyle, NP will conclude with a practical synopsis of best practices for team-based treatment and management of patients with psoriatic arthritis, addressing the challenges presented by comorbidities and unmet needs in the PsA patient population.
Rheumatologists, dermatologists, NPs and PAs who help manage patients with psoriatic arthritis
Review the current pathophysiology and therapeutic targets for PsA, modes of action of current and emerging oral therapies, and unmet patient needs in the management of PsA
Analyze the most up to date clinical trial data for current and emerging oral treatments, including TYK2 blockers for patients with PsA
Discuss the potential patient selection and clinical applications for newer oral therapies in PsA, including patient preferences, tolerability of side effects, and comorbidities
a. Review of Immunopathology and Therapeutic Targetsb. Current Oral Therapiesc. The Mechanism of Action of TYK2 Inhibitorsd. Unmet Patient Needs and Comorbidity Concerns
a. JAK Inhibitorsb. IL-23 Inhibitorsc. TYK2 Inhibitors
a. Potential Applications and Considerations When Individualizing Treatmentsb. Adherence to Treatmentc. Optimizing Quality of Life
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships with ineligible companies. Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty
have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.
| Faculty | Relationship Identified With: |
| Rebecca Haberman, MD | Consultant/Advisor: Johnson and Johnson; Novartis AG; UCB S.A |
| Margaret A. Coyle, NP | Nothing to disclose |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Nicole McMenamin and Chelsey Simonds hereby state that they do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
AcademicCME designates this enduring material for a maximum of 1.0 CNE Contact Hour, including 1.0 Pharmacotherapeutic Contact Hour (Provider #P0491).
This activity has been supported by an independent educational grant from Bristol Myers Squibb.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Bristol Myers Squibb do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to claim credit, participants must complete the following:
For all CE inquiries or special needs, please contact admin@academiccme.com.
811 S. Orleans Ave. Tampa, Fl 33606
